Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 1, 1997, Pages 48-55

  De Sarro, Angela ^a   Grasso, Silvana ^b   Zappalà, Maria ^b   Nava, Felice ^c   De Sarro, Giovambattista ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

2 Isobutyl 1 methylxanthine; Caffeine; Diprophylline; Enprofylline; Etofylline; Genetically epilepsy prone rat and epilepsy; Theophylline

Indexed keywords

8 CHLOROTHEOPHYLLINE; ADENOSINE RECEPTOR; CAFFEINE; DIPROPHYLLINE; DOXOFYLLINE; ENPROFYLLINE; ETOFYLLINE; ISOBUTYLMETHYLXANTHINE; THEOBROMINE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; EPILEPSY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

1-METHYL-3-ISOBUTYLXANTHINE; ACOUSTIC STIMULATION; ANIMALS; CAFFEINE; CONVULSANTS; DYPHYLLINE; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; LIPID METABOLISM; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; THEOBROMINE; THEOPHYLLINE; XANTHINES;

EID: 0030997616     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005027     Document Type: Article

References (61)

1. 2 receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur J Pharmacol 294:383-389
2. Albertson TE, Joy RM, Stark LG (1983) Caffeine modification of kindled amygdaloid seizures. Pharmacol Bioehein Behav 19:339-344
3. Ali H, Cunha-Melo JR, Saul WF, Beaven MA (1990) Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. J Biol Chem 265:745-753
4. Ali H, Muller CE, Daly JW, Beaven MA (1991) Methylxanthines block antigen-induced responses in RBL-2H3 cells indipendently of adenosine receptors or cyclic AMP: evidence for inhibition of antigen binding to IgE. J Pharmacol Exp Ther 258:954-962
5. 3-Alkylxanthines in rats. J Pharm Pharmac 143:262-269
6. Ault B, Olney MA, Joyner JL, Boyer CE, Notrica MA, Soroko FE, Wang CM (1987) Proconvulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporale lobe epilepsy. Brain Res 426:93-102
7. Avico U, De Martiis F, Toffoli F (1962) Diossolani ed 1,3-diossani xantinici. Il Farmaco Ed Sc 17:73-80
8. Barraco RA, Swanson TH, Phillis JW, Berman RF (1984) Anticonvulsant effects of adenosine analogues on amygaloid-kindled seizures in rats. Neurosci Lett 46: 317-322
9. Boyce CBC, Milborrow BV (1965) A simple assessment of partition data for correlating structure and biological activity using thin-layer chromatography. Nature 208:537-539
10. 3H)-phenylxanthine. Proc Natl Acad Sci USA 77:5547-5551
11. Cirillo R, Barone D, Franzone JS (1988) Doxofylline, an antiasthmatic drug lacking affinity for adenosine receptors. Arch Int Pharmacodyn Ther 295:221-237
12. Corradetti R, Lo Conte R, Moroni F, Passani MB, Pepeu G (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 104:19-26
13. Cutrufo C, Bortot L, Giachetti A, Manzini S (1992) Differential effects of various xanthines on pentylenetetrazole-induced seizures in rats: an EEG and behavioural study. Eur J Pharmacol 222:1-6
14. Czuczwar SJ, Jackel R, Loscher W (1987a) Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res 1:234-238
15. Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987b) Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28:383-386
16. Czuczwar SJ, Gasior M, Janusz W, Szczepanik B, Wlodarczyk D, Kleinrok Z (1990) Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 31:318-323
17. Daly JW, Bruns RF, Snyder SH (1981) Adenosine receptors in the central nervous system, relationship to the central actions of methylxanthines. Life Sci 28:2083-2097
18. Daly JW, Padgett W, Shamim MT (1985) Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J Med Chem 29:1305-1308
19. De Sarro A, De Sarro GB (1991) Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. Neuropharmacology 30:169-176
20. De Sarro G, De Sarro A, Meldrum BS (1991) Anticonvulsant action of 2-chloroadenosine injected focally into the inferior colliculus and substantia nigra. Eur J Pharmacol 194:145-152
21. De Sarro G, Di Paola ED, De Sarro A (1996a) Effects of compounds acting on different adenosine receptor subtypes on audiogenic seizures in DBA/2 mice. BPS Winter Meeting, abstract book, P222
22. 1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene. Eur J Pharmacol 317:239-245
23. Dragunow M (1990) Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophylline. Pharmacol Biochem Behav 36: 751-755
24. Dragunow M, Goddard GV, Laverty R (1985) Is adenosine an endogenous anticonvulsant? Epilepsia 26:480-487
25. Dunwiddie TV, Worth T (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 220: 70-76
26. Dunwiddie TV, Hoffer BJ, Fredholm BB (1981) Alkylxanthines elevate hippocampal excitability. Naunyn-Schmiedeberg's Arch Pharmacol 316:326-330
27. Fredholm BB (1980) Are the actions of methylxanthines due to antagonism of adenosine? Trends Pharmacol Sci 1:129-132
28. Fredholm BB, Hedquist P (1980) Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol 29:1635-1645
29. Georgiev V, Johansson B, Fredholm BB (1993) Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 612:271-277
30. 2-adenosine receptor antagonists. J Med Chem 37:1526-1534
31. Jacobson KA, van Galen PJM, Williams M (1992) Adenosine receptors: pharmacology, structure activity relationships, and therapeutic potential. J Med Chem 35:407-422
32. Jacobson KA, Shi D, Gallo-Rodriguez C, Manning M, Muller C, Daly JW, Neumeyer JL, Kiriasis L, Pfleiderer W (1993) Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. J Med Chem 36:2639-2644
33. Jacobson KA, Von Lubitz DKJE, Daly JW, Fredholm BB (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108-113
34. 2 receptor ligands in different chemoconvulsive rodent models. Eur J Pharmacol 242:221-228
35. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluation dose-effect experiments. J Pharmacol Exp Ther 96: 99-113
36. Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77: 2551-2554
37. Manzini S, Meini S, Giachetti A, Beani L, Borea A, Antonelli T, Ballati L, Bacciarelli C (1990) Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions. Arzeim Forsch/Drug Res 40:1205-1213
38. Muller CE, Shi D, Manning M, Daly JW (1993) Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at 3-position: structure-activity relationships at adenosine receptors. J Med Chem 36:3341-3349
39. 1 adenosine receptor mediated modulation of seizure susceptibility. In: Nisticò G, Morselli PL, Lloyd KG, Fariello RG, Engel J (eds) Neurotransmitters, seizures and Epilepsy III. Raven Press, New York, pp 341-353
40. Murray TF, Sylvester CS, Schultz CS, Szot P (1985) Purinergic modulation of seizure threshold for pentylentetrazole in the rat. Neuropharmacology 24:761-766
41. 2a receptors. Trends Pharmacol Sci 17: 364-372
42. Perkins MN, Stone TW (1980) Aminophylline and theophylline derivatives as antagonists of neuronal depression by adenosine: a microiontophoretic study. Arch Int Pharmacodyn 246: 205-214
43. Persson CGA (1982) Universal adenosine receptor antagonism is neither necessary nor desiderable with xanthine antiasthmatics. Med Hypotheses 8:515-526
44. Persson CGA (1986) Development of safer xanthine drugs for treatment of obstructive airways disease. J Allergy Clin Immun 78: 817-824
45. Persson CGA, Erjefalt I (1982) Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different mechanisms of action. Arch Int Pharmacodyn 258:267-282
46. Persson CGA, Kjellin G (1981) Enprofylline, a principally new antiasthmatic xanthine. Acta Pharmacol Toxicol 49:313-316
47. Persson CGA, Karlsson JA, Erjefalt I (1982) Differentiation between bronchodilatation and universal adenosine antagonism among xanthine derivatives. Life Sci 30:2181-2189
48. Schubert P, Lee KS (1986) Non-synaptic modulation of repetitive firing by adenosine is antagonized by 4-aminopyridine in rat hippocampal slice. Neurosci Lett 67:334-338
49. Schubert P, Heinemann U, Kolb R (1986) Differential effects of adenosine on pre- and postsynaptic calcium fluxes. Brain Res 376:382-386
50. 2 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 330:212-221
51. Sebastiao AM, Ribeiro JA (1990) Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br J Pharmacol 100:55-62
52. Segev S, Rehavi M, Rubistein E (1988) Quinolones, theophylline and diclofenac interactions with the γ-aminobutyric acid receptor. Antimicrob Agents Chemother 32:1624-1626
53. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioural actions of methylxanthines. Proc Natl Acad Sci USA 78:3260-3264
54. Stone WE, Javid MJ (1980) Aminophylline and imidazole as convulsants. Arch Int Pharmacodyn 248:120-131
55. Turski WA, Cavalheiro EA, Ikonomidou C, Mello LE. Bortolotto ZA, Turski L (1985) Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: morphological and electroencephalographic correlates. Brain Res 361:309-323
56. Ukena D, Schirren CG, Schwabe U (1985) Effetcts of enprofylline on A1 and A2 adenosine receptors. Eur J Pharmacol 117:25-33
57. Van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999-1005
58. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 249:265-270
59. 1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 253:95-99
60. 3 receptor stimulation on seizures in mice. Eur J Pharmacol 275:23-29
61. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436